What is it about?
Screening endoscopy is recommended for early detection of esophageal varices (EVs) in cirrhotic patients with portal hypertension. However, this approach is limited by its invasiveness and cost. The aim of the study was to determine if platelet count can predict the presence of EVs, especially large (grade III, IV) EVs in need of prophylactic therapy, in a cohort of Egyptian patients with liver cirrhosis. In all, 110 patients with cirrhosis were prospectively analyzed.
Featured Image
Why is it important?
Screening endoscopy is recommended for early detection of esophageal varices (EVs) in cirrhotic patients with portal hypertension. However, this approach is limited by its invasiveness and cost. The aim of the study was to determine if platelet count can predict the presence of EVs, especially large (grade III, IV) EVs in need of prophylactic therapy, in a cohort of Egyptian patients with liver cirrhosis. In all, 110 patients with cirrhosis were prospectively analyzed.
Perspectives
Cirrhotic patients with normal platelet counts (above 150,000), especially in financially deprived developing countries, can avoid screening endoscopy as they are at a low risk for variceal bleeding, and presence of large EVs in these patients is much less common than in those with thrombocytopenia. A 3.175 cut-off value of FIB-4 could be useful as a noninvasive predictor of large varices requiring prophylactic banding in cirrhotic patients. PMID: 27281094 PMCID: PMC4907672 DOI: 10.1097/MD.0000000000003853
sherief Abd-Elsalam
Tanta University
Read the Original
This page is a summary of: Correlation of platelets count with endoscopic findings in a cohort of Egyptian patients with liver cirrhosis, Medicine, June 2016, Wolters Kluwer Health,
DOI: 10.1097/md.0000000000003853.
You can read the full text:
Resources
Contributors
The following have contributed to this page
